fluorobenzenes has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drazen, JM; Gelijns, AC | 1 |
| Fedin, AN; Kuzubova, NA; Lebedeva, ES; Titova, ON | 1 |
| Einvik, G; Hagve, TA; Høiseth, AD; Lehmann, S; Neukamm, A; Omland, T; Søyseth, V | 1 |
1 trial(s) available for fluorobenzenes and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
Topics: Aged; Biomarkers; C-Reactive Protein; Double-Blind Method; Endothelium, Vascular; Female; Fluorobenzenes; Forced Expiratory Volume; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Lung; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vital Capacity | 2015 |
2 other study(ies) available for fluorobenzenes and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Statin strikeout.
Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Simvastatin; Sulfonamides | 2014 |
[Effect of endotelioprotectors on the tone of pulmonary arteries and bronchi in the model of obstructive lung pathology].
Topics: Animals; Bronchi; Disease Models, Animal; Endothelium, Vascular; Fluorobenzenes; Glycosaminoglycans; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitrogen Dioxide; Protective Agents; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Vasodilation | 2014 |